Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer

European Urology 2026 Open access

Read full text
Authors: Valentina Tateo, Giuseppe Basile, Patrizia Giannatempo, Joep J. de Jong, James A. Proudfoot, Brigida A. Maiorano, Antonio Cigliola, Chiara Mercinelli, Elai Davicioni, Marco Moschini, Giovanni Tremolada, Simone Rota
+5 more Giorgio Brembilla, Maurizio Colecchia, Francesco De Cobelli, Francesco Montorsi, Andrea Necchi
DOI: 10.1016/j.eururo.2026.01.015
Cited by: 7
References: 12

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers Ferroptosis and cancer prognosis

Publication details

Journal / source
European Urology
Publisher
Elsevier BV
Volume
90
Issue
1
Pages
7–12
Publication date
3 February 2026
Language
EN